Last week saw a large number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here’s why brokers think investors ought to buy them next week:
Aristocrat Leisure Limited (ASX: ALL)
According to a note out of UBS, its analysts have retained their buy rating and $29.60 price target on this gaming technology company’s shares. The broker notes that an industry survey shows that Aristocrat’s gaming machine sales fell less than expected during the June quarter. It also shows that its games are in demand, with three out of the top five premium leased machines belonging to Aristocrat. Though, it has warned that its second half earnings could underwhelm due to casino closures. I agree with UBS and believe Aristocrat Leisure would be a great long term investment option.
Corporate Travel Management Ltd (ASX: CTD)
A note out of Ord Minnett reveals that its analysts have upgraded this corporate travel company’s shares to a buy rating with an improved price target of $12.97. According to the note, Ord Minnett believes it has more than enough liquidity to ride out the pandemic. It notes that this is a luxury that many of its competitors do not have. In light of this, the broker appears to believe Corporate Travel Management could come out of the crisis in a stronger position. Although I think Ord Minnett makes some great points, I intend to wait for the crisis to pass before considering an investment.
CSL Limited (ASX: CSL)
Another note out of UBS reveals that its analysts have retained their buy rating and $331.00 price target on this biotherapeutics company’s shares ahead of its full year results in August. According to the note, the broker expects CSL to deliver a 15% increase in profit in FY 2020. And while it notes that CSL is facing headwinds in FY 2021, it appears optimistic that its vaccine sales will offset some of this. I agree with UBS on this one as well and would be a buyer of its shares.
Legendary stock picker names 5 cheap stocks to buy right now
Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.
These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- ASX gold miners on watch after gold price crashes lower – August 12, 2020 7:28am
- 5 things to watch on the ASX 200 on Wednesday – August 12, 2020 7:10am
- 3 mid cap ASX shares that could generate strong long term returns – August 11, 2020 6:00pm